Holen Sie sich die Stockscreener-App
2.63
3.31%
-0.09
Handel nachbörslich:
2.63
Schlusskurs vom Vortag:
$2.72
Offen:
$2.77
24-Stunden-Volumen:
927.09K
Relative Volume:
2.18
Marktkapitalisierung:
$62.28M
Einnahmen:
$156.31M
Nettoeinkommen (Verlust:
$-245.76M
KGV:
-3.0941
EPS:
-0.85
Netto-Cashflow:
$-234.16M
1W Leistung:
-32.56%
1M Leistung:
-43.07%
6M Leistung:
-75.78%
1J Leistung:
-80.94%
1-Tages-Spanne:
$2.5213
$2.89
1-Wochen-Bereich:
$2.5213
$3.72
52-Wochen-Spanne:
$2.5213
$19.69
Agenus Inc Stock (AGEN) Company Profile
Firmenname
Agenus Inc
Sektor
Branche
Telefon
781-674-4410
Adresse
3 FORBES ROAD, LEXINGTON, MA
Vergleichen Sie AGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AGEN | 2.63 | 62.28M | 156.31M | -245.76M | -234.16M | -0.85 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-06 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-28 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-04-22 | Eingeleitet | B. Riley FBR | Buy |
| 2016-10-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Bestätigt | Maxim Group | Buy |
| 2016-03-11 | Hochstufung | Maxim Group | Hold → Buy |
| 2015-12-16 | Eingeleitet | Jefferies | Buy |
| 2015-10-27 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-07-27 | Bestätigt | MLV & Co | Buy |
| 2015-06-11 | Eingeleitet | Oppenheimer | Outperform |
| 2015-01-12 | Bestätigt | Maxim Group | Buy |
| 2015-01-09 | Bestätigt | MLV & Co | Buy |
| 2015-01-09 | Bestätigt | Maxim Group | Buy |
| 2014-12-19 | Bestätigt | Maxim Group | Buy |
| 2014-05-08 | Bestätigt | Maxim Group | Buy |
| 2014-03-14 | Bestätigt | MLV & Co | Buy |
| 2013-10-08 | Bestätigt | Maxim Group | Buy |
| 2012-01-05 | Eingeleitet | William Blair | Outperform |
| 2011-12-01 | Eingeleitet | Global Hunter Securities | Buy |
Alle ansehen
Agenus Inc Aktie (AGEN) Neueste Nachrichten
Agenus Inc. (NASDAQ:AGEN) Short Interest Update - MarketBeat
William Blair Weighs in on Agenus' Q4 Earnings (NASDAQ:AGEN) - MarketBeat
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
Biotech Brass Misled Investors About Cancer Drugs, Suit Says - Law360
Agenus Top Brass Sued Over FDA Response to Cancer Drug Trial - Bloomberg Law
Agenus Inc. (NASDAQ:AGEN) Q3 2024 Earnings Call Transcript - Insider Monkey
Q3 2024 Agenus Inc Earnings Call - Cbainfo
Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating F - GuruFocus.com
Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ... - Yahoo Finance
Agenus Inc. Reports Progress in Immunotherapy Development - TipRanks
Agenus: Q3 Earnings Snapshot - Houston Chronicle
Agenus Reports Third Quarter 2024 Financial Results - citybiz
Agenus (AGEN) Q3 2024 Earnings Call Transcript - AOL
Agenus reports Q3 EPS ($3.08) vs ($3.29) last year - TipRanks
HC Wainwright Issues Pessimistic Forecast for Agenus (NASDAQ:AGEN) Stock Price - MarketBeat
Agenus Inc (AGEN) Q3 2024 Earnings: EPS Miss, Revenue at $25.1M vs. $61.48M Estimate - GuruFocus.com
Agenus Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Agenus Q3 Revenue Edges Up Despite Cash Concerns; BOT/BAL Shows Promise in Cancer Trials | AGEN Stock News - StockTitan
Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result - GuruFocus.com
Agenus stock hits 52-week low at $3.82 amid market challenges - Investing.com India
Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024 - Business Wire
Agenus to Showcase Breakthrough Cancer Immunotherapy Data at SITC 2024 Meeting | AGEN Stock News - StockTitan
Agenus (AGEN) Set to Announce Earnings on Tuesday - MarketBeat
AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Invest - GuruFocus.com
Agenus announces director Wiinberg's resignation and advisory role - Investing.com
AGENAgenus Inc. Latest Stock News & Market Updates - StockTitan
Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update - Business Wire
Shareholders that lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about pending Class ActionAGEN - PR Newswire
Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024AGEN - PR Newswire
Investors in Agenus Inc. Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - PR Newswire
Class Action Filed Against Agenus Inc. (AGEN)November 5, 2024 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - The Malaysian Reserve
AGEN Stockholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming DeadlinesAGEN - PR Newswire
Agenus stock hits 52-week low at $4.17 amid market challenges - Investing.com Australia
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Agenus to Contact Us to Have Their Losses Evaluated Today - GlobeNewswire Inc.
Agenus stock hits 52-week low at $4.17 amid market challenges By Investing.com - Investing.com South Africa
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities F - GuruFocus.com
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Agenus Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationAGEN - PR Newswire
Agenus Inc. Investors: Please contact the Portnoy Law Firm - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - GlobeNewswire
AGEN Shareholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
Finanzdaten der Agenus Inc-Aktie (AGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):